Berger Dietmar Insider Trades

Insider Trading History

Track insider trading activity for Berger Dietmar. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gilead Sciences
Gilead Sciences GILD
Chief Medical Officer
Holding Value $6.13M 47,461 shares
Last Trade
Mar 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.93M 39,890 shares
$148.56
$129.18
Gilead Sciences
Gilead Sciences GILD
Chief Medical Officer
Holding Value $5.04M 39,046 shares
Last Trade
Mar 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$317k 2,133 shares
$148.56
$129.18
Gilead Sciences
Gilead Sciences GILD
Chief Medical Officer
Holding Value $2.59M 20,045 shares
Last Trade
Mar 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$317k 2,133 shares
$148.56
$129.18
Gilead Sciences
Gilead Sciences GILD
Chief Medical Officer
Holding Value $2.45M 18,982 shares
Last Trade
Mar 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$158k 1,063 shares
$148.56
$129.18
Gilead Sciences
Gilead Sciences GILD
Chief Medical Officer
Holding Value $2.31M 17,912 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 8,530 shares
$148.95
$129.18
Gilead Sciences
Gilead Sciences GILD
Chief Medical Officer
Holding Value $1.21M 9,382 shares
Last Trade
Jan 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$844k 6,944 shares
$121.60
$129.18
Gilead Sciences
Gilead Sciences GILD
Chief Medical Officer
Holding Value $5.32M 41,179 shares
Last Trade
Jan 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.99M 16,326 shares
$121.60
$129.18
Gilead Sciences
Gilead Sciences GILD
Chief Medical Officer
Holding Value $2.11M 16,326 shares
Last Trade
Jan 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.99M 16,326 shares
$121.60
$129.18
Gilead Sciences
Gilead Sciences GILD
Chief Medical Officer
Holding Value $7.43M 57,505 shares
Last Trade
Mar 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.42M 37,710 shares
$117.21
$129.18
Gilead Sciences
Gilead Sciences GILD
Chief Medical Officer
Holding Value $6.33M 48,975 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.5M 48,975 shares
$91.88
$129.18
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Global Head Of R&d
Holding Value $880k 85,678 shares
Last Trade
May 07, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.62M 4,322 shares
$836.50
$10.27
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Global Head Of R&d
Holding Value $924k 90,000 shares
Last Trade
Mar 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.2M 15,000 shares
$945.75
$10.27
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Global Head Of R&d
Holding Value $770k 75,000 shares
Last Trade
Feb 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.1M 75,000 shares
$961.75
$10.27
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Global Head Of R&d
Holding Value $873k 85,000 shares
Last Trade
May 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142M 135,000 shares
$1,051.25
$10.27

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up